Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Money saving alternatives

At the time I didn't poo poo the MMP rather I said that the revenues could be used to support profitable M&A, which could lead to even greater revenue potential. Not quite the same as your version.

With M&A halted, obviously the MMP is the only source of substantial potential revenue.

Adapt to the known facts at hand, not applying current circumstances to past events.

If you think back further, you will see that I am all for a BoD change when appropriate.

.

.

.

Be well

Share
New Message
Please login to post a reply